Profile: Louisville Apl Diagnostics, Inc. is a manufacturer and marketer of products for the in vitro detection of antiphospholipid antibodies. These include the APhL® Elisa kit and APL® Elisa kit for the detection of IgG, IgM, IgA & aPL. We also offer calibrators, positive samples & positive controls for anticardiolipin and ß2 glycoprotein 1 for research use. We provide calibrators for the determination of IgG and IgM aCL antibodies, obtained by mixing various proportions of sera from IgG aCL high positive, and pooled normal human serum. We offer various series of positive controls, which are LAPL-GM-003H, LAPL-GM-003M, LAPL-GM-003L, LAPL-GM-004M, LAPL-GM-004L and LAPL-MM-004H. The LAPL-MM-004H single vial has blended lyophilized high positive control sera of IgM, aCL antibodies and reconstituted with 1000µL dH20, where each vial contains sera yielding capacity that is greater than 80 MPL units.
The company was founded in 1993, has revenues of < USD 1 Million and is ISO, CE certified.
FDA Registration Number: 1529254
7 Products/Services (Click for related suppliers)
|
• B2 - Glycoprotein I Antibodies Test System (FDA Code: MSV / 866.5660) A multiple autoantibodies immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the autoantibodies (antibodies produced against the body's own tissues) in serum and other body fluids. Measurement of multiple autoantibodies aids in the diagnosis of autoimmune disorders (disease produced when the body's own tissues are injured by autoantibodies). |
• Calibrators |
• Diabetes Immunodiagnostic Products |
• Dialysis Immunoassay Systems |
• ELISA Kits, Gliadin IgA |
• ELISA Kits, Gliadin IgG |
• Immunological Anticardiolipin Test System (FDA Code: MID / 866.5660) |